Literature DB >> 1371127

Human postnatal thymocytes generate phenotypically immature CD3dim, CD5dim, CD1abright progeny in organ culture.

M Merkenschlager1, A G Fisher.   

Abstract

We previously described an organ culture system that supports the in vitro development of human fetal thymocytes in murine alymphoid thymic rudiments without addition of exogenous factors. This approach to study human T cell precursors is limited by the requirement for fetal tissue. We show that human thymocytes from pediatric sources can be expanded under similar conditions. Organ cultures generated predominantly CD4 CD8 double positive cells, most of which maintained the phenotype CD3dim, CD5dim, and CD1abright, characteristic for double positive thymocytes ex vivo. This culture system should facilitate in vitro studies on human thymocyte development and repertoire selection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371127

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Selective manipulation of the human T-cell receptor repertoire expressed by thymocytes in organ culture.

Authors:  M Merkenschlager; A G Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

2.  Differentiation of CD3-4-8- human fetal thymocytes in vivo: characterization of a CD3-4+8- intermediate.

Authors:  D L Kraft; I L Weissman; E K Waller
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

3.  Human bone marrow and umbilical cord blood cells generate CD4+ and CD8+ single-positive T cells in murine fetal thymus organ culture.

Authors:  H Yeoman; R E Gress; C V Bare; A G Leary; E A Boyse; J Bard; L D Shultz; D T Harris; D DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

4.  Identification of lymphomyeloid primitive progenitor cells in fresh human cord blood and in the marrow of nonobese diabetic-severe combined immunodeficient (NOD-SCID) mice transplanted with human CD34(+) cord blood cells.

Authors:  C Robin; F Pflumio; W Vainchenker; L Coulombel
Journal:  J Exp Med       Date:  1999-05-17       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.